Kurt Macalpine Bought 19710 shares of WisdomTree Investments, Inc. (WETF) in an Insider Trading; 14 Analysts Are Bullish Evolent Health, Inc. (EVH) Last Week

It was revealed in a legally required report which was filled with the Washington-based Security and Exchange Commission that Kurt Macalpine, who works for Wisdomtree Investments Inc, and currently serves as Global Head of Distribution finalized an insider deal on 07-02-2018. He bought 19,710 shares of the New York-based company at an average $10.4 U.S. Dollars a share. As exposed in the legal report available for free here, the full amount of the deal was $204,647 U.S. Dollars. This investment decreased his ownership of Wisdomtree Investments Inc to 0.14% market cap or 184,056 shares.

Among 14 analysts covering Evolent Health (NYSE:EVH), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Evolent Health had 37 analyst reports since August 7, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Buy” rating and $3000 target in Wednesday, August 9 report. The firm has “Buy” rating by SunTrust given on Wednesday, September 20. The rating was maintained by KeyBanc Capital Markets on Wednesday, January 10 with “Buy”. The firm has “Buy” rating given on Tuesday, January 2 by Cantor Fitzgerald. Jefferies maintained the stock with “Buy” rating in Monday, August 21 report. The rating was maintained by Robert W. Baird on Sunday, September 24 with “Buy”. Oppenheimer maintained the stock with “Buy” rating in Tuesday, August 8 report. Canaccord Genuity maintained the stock with “Buy” rating in Friday, October 6 report. Robert W. Baird maintained Evolent Health, Inc. (NYSE:EVH) on Wednesday, June 14 with “Buy” rating. Oppenheimer maintained it with “Buy” rating and $2800 target in Wednesday, June 21 report. See Evolent Health, Inc. (NYSE:EVH) latest ratings:

11/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $25.0 Maintain
10/01/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $19.0 Maintain
02/01/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $30.0 Maintain
11/12/2017 Broker: Canaccord Genuity Rating: Buy New Target: $27.0 Maintain
16/11/2017 Broker: Leerink Swann Rating: Buy New Target: $25.0 Maintain
10/11/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $30.0 Maintain
07/11/2017 Broker: Goldman Sachs Rating: Buy New Target: $16.0
02/11/2017 Broker: Jefferies Rating: Buy New Target: $28.0 Maintain
31/10/2017 Broker: Robert W. Baird Rating: Buy New Target: $25.0 Maintain
06/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $32.0 Maintain

The stock increased 2.47% or $0.25 during the last trading session, reaching $10.37. About 1.13M shares traded. WisdomTree Investments, Inc. (NASDAQ:WETF) has declined 9.35% since February 7, 2017 and is downtrending. It has underperformed by 26.05% the S&P500.

Among 12 analysts covering WisdomTree Investments (NASDAQ:WETF), 4 have Buy rating, 3 Sell and 5 Hold. Therefore 33% are positive. WisdomTree Investments has $31 highest and $6.50 lowest target. $15.83’s average target is 52.65% above currents $10.37 stock price. WisdomTree Investments had 48 analyst reports since August 4, 2015 according to SRatingsIntel. Citigroup maintained the shares of WETF in report on Tuesday, October 31 with “Buy” rating. As per Tuesday, October 10, the company rating was maintained by Jefferies. The rating was maintained by Keefe Bruyette & Woods on Thursday, December 21 with “Hold”. Citigroup upgraded the stock to “Neutral” rating in Monday, February 6 report. The firm earned “Sell” rating on Sunday, August 13 by Keefe Bruyette & Woods. As per Monday, September 21, the company rating was downgraded by Morgan Stanley. The rating was maintained by Northland Capital on Friday, September 15 with “Hold”. Northland Capital downgraded the shares of WETF in report on Wednesday, June 1 to “Market Perform” rating. The rating was maintained by Jefferies with “Buy” on Wednesday, January 10. The stock of WisdomTree Investments, Inc. (NASDAQ:WETF) earned “Neutral” rating by Bank of America on Tuesday, June 28.

Investors sentiment decreased to 1.14 in 2017 Q3. Its down 0.03, from 1.17 in 2017Q2. It is negative, as 22 investors sold WisdomTree Investments, Inc. shares while 56 reduced holdings. 24 funds opened positions while 65 raised stakes. 118.39 million shares or 5.96% less from 125.89 million shares in 2017Q2 were reported. Loomis Sayles L P accumulated 0% or 15 shares. Blackrock has invested 0.01% of its portfolio in WisdomTree Investments, Inc. (NASDAQ:WETF). Alpha Cubed Investments Limited Liability has invested 0.03% in WisdomTree Investments, Inc. (NASDAQ:WETF). Putnam Investments Ltd Limited Liability Company holds 0.03% or 1.38M shares. American Group reported 91,317 shares stake. 1,825 were reported by First Personal. Aspen Investment invested 0.35% in WisdomTree Investments, Inc. (NASDAQ:WETF). Sei Invs holds 0.04% of its portfolio in WisdomTree Investments, Inc. (NASDAQ:WETF) for 1.19 million shares. Quantbot Techs Ltd Partnership owns 3,152 shares. Mason Street Advsrs Ltd reported 29,133 shares or 0.01% of all its holdings. First Manhattan owns 4,617 shares. 35,378 are held by Redmond Asset Lc. Blair William & Co Il holds 0.01% or 67,878 shares in its portfolio. Arrowmark Colorado Ltd Liability accumulated 8.60M shares. Suntrust Banks Incorporated reported 35,714 shares stake.

WisdomTree Investments, Inc., through its subsidiaries, operates as an exchange-traded funds sponsor and asset manager. The company has market cap of $1.40 billion. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. It has a 47.14 P/E ratio. The firm also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.

Since December 15, 2017, it had 0 insider buys, and 1 insider sale for $585,370 activity. SALERNO FRANK sold $585,370 worth of WisdomTree Investments, Inc. (NASDAQ:WETF) on Friday, December 15.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States. The company has market cap of $1.09 billion. It operates as a managed services firm that supports integrated health systems in migration toward value care and population health management. It currently has negative earnings. The companyÂ’s services include providing clients with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.

The stock increased 1.81% or $0.25 during the last trading session, reaching $14.05. About 305,323 shares traded. Evolent Health, Inc. (NYSE:EVH) has risen 80.60% since February 7, 2017 and is uptrending. It has outperformed by 63.90% the S&P500.